Canada Markets close in 4 hrs 41 mins

DiaMedica Therapeutics Inc. (DMAC)

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
5.45+0.15 (+2.83%)
As of 11:15AM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous Close5.30
Open5.39
Bid5.34 x 1100
Ask5.45 x 800
Day's Range5.37 - 5.49
52 Week Range1.70 - 8.80
Volume23,738
Avg. Volume92,001
Market Cap77.058M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • DiaMedica Provides a Business Update and Second Quarter 2020 Financial Results
    Business Wire

    DiaMedica Provides a Business Update and Second Quarter 2020 Financial Results

    DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for kidney diseases and neurological disorders, today provided a business update and financial results for the three and six months ended June 30, 2020. DiaMedica will host a conference call tomorrow, August 12, 2020, at 7:00 a.m. Central Time to discuss its business update and second quarter financial results.